Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region (Q34085107)

30 July 2017

Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region (English)

1 reference

30 July 2017

1 reference

Leszek Nosek

1

1 reference

30 July 2017

Hans-Veit Coester

2

1 reference

30 July 2017

Carsten Roepstorff

3

1 reference

30 July 2017

Henrik F Thomsen

4

1 reference

30 July 2017

Niels R Kristensen

5

1 reference

30 July 2017

Hanne Haahr

6

1 reference

30 July 2017

Tim Heise

7

1 reference

30 July 2017

1 September 2014

1 reference

Clinical Drug Investigation

30 July 2017

1 reference

30 July 2017

34

1 reference

30 July 2017

673-679

1 reference

30 July 2017

9

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

30 July 2017

start time

16 August 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143594

Insulin preparations with prolonged effect

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143594

A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143594

Poor glycaemic control caused by insulin induced lipohypertrophy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143594

Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4143594

Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.

5 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-014-0218-X

Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-014-0218-X

Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-014-0218-X

Biotransformation of insulin glargine after subcutaneous injection in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-014-0218-X

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-014-0218-X

Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40261-014-0218-X

Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels

21 January 2018

1 reference

12 December 2020

Removing barriers to insulin use

1 reference

12 December 2020

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes

1 reference

12 December 2020

Soluble, prolonged-acting insulin derivatives. I. Degree of protraction and crystallizability of insulins substituted in the termini of the B-chain

1 reference

12 December 2020

Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study

1 reference

12 December 2020

Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site

1 reference

12 December 2020

Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen

1 reference

12 December 2020

Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry

1 reference

12 December 2020

10.1007/S40261-014-0218-X

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference